Amprion To Expand Diagnostic Testing For Neurodegenerative Disorders With Investment From Decathlon Capital Partners
Agreement provides flexible amortization without dilution or loss of management controlSAN DIEGO, July 8, 2026 /PRNewswire/ — Amprion, Inc., a global leader advancing diagnosis of neurodegenerative disorders through seed-amplification testing, has reached an agreement with Decathlon Capital Partners…
News provided by PR Newswire.
